Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,958 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features.
Natsumeda M, Chang M, Gabdulkhaev R, Takahashi H, Tsukamoto Y, Kanemaru Y, Okada M, Oishi M, Okamoto K, Rodriguez FJ, Kakita A, Fujii Y, Schreck KC. Natsumeda M, et al. Among authors: chang m. Brain Tumor Pathol. 2021 Jul;38(3):228-233. doi: 10.1007/s10014-021-00407-0. Epub 2021 Jul 3. Brain Tumor Pathol. 2021. PMID: 34216310
Druggable genomic landscapes of high-grade gliomas.
Ghanem P, Fatteh M, Kamson DO, Balan A, Chang M, Tao J, Blakeley J; Johns Hopkins Molecular Tumor Board Investigators; Canzoniero J, Grossman SA, Marrone K, Schreck KC, Anagnostou V. Ghanem P, et al. Among authors: chang m. Front Med (Lausanne). 2023 Dec 8;10:1254955. doi: 10.3389/fmed.2023.1254955. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38143440 Free PMC article.
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma.
Schreck KC, Strowd RE, Nabors LB, Ellingson BM, Chang M, Tan SK, Abdullaev Z, Turakulov R, Aldape K, Danda N, Desideri S, Fisher J, Iacoboni M, Surakus T, Rudek MA, Bettegowda C, Grossman SA, Ye X. Schreck KC, et al. Among authors: chang m. Clin Cancer Res. 2024 May 15;30(10):2048-2056. doi: 10.1158/1078-0432.CCR-23-3241. Clin Cancer Res. 2024. PMID: 38446982 Clinical Trial.
PAM-free diagnostics with diverse type V CRISPR-Cas systems.
Rananaware SR, Meister KS, Shoemaker GM, Vesco EK, Sandoval LSW, Lewis JG, Bodin AP, Karalkar VN, Lange IH, Pizzano BLM, Chang M, Ahmadimashhadi MR, Flannery SJ, Nguyen LT, Wang GP, Jain PK. Rananaware SR, et al. Among authors: chang m. medRxiv [Preprint]. 2024 May 3:2024.05.02.24306194. doi: 10.1101/2024.05.02.24306194. medRxiv. 2024. PMID: 38746294 Free PMC article. Preprint.
9,958 results